Niva Bupa Health Insurance Company Limited has announced its audited financial results for the quarter and financial year ended March 31, 2026. The company’s Board of Directors approved the results on May 08, 2026, showcasing significant growth in gross premiums and a transition to profitability for the quarter. During the current quarter, the Gross Premiums Written stood at ₹2,87,968 Lakhs, marking a 38.54% increase from ₹2,07,865 Lakhs in the same quarter last year and a 29.06% rise from ₹2,23,127 Lakhs in the previous quarter. Profit After Tax reached ₹34,513 Lakhs for the quarter, compared to a profit of ₹20,608 Lakhs YoY and a loss of ₹8,764 Lakhs QoQ.
| Particulars (Rs. in Lakhs) | Q4 FY26 | Q3 FY26 | Q4 FY25 | % Change (QoQ) | % Change (YoY) |
| Gross Premiums Written | 2,87,968 | 2,23,127 | 2,07,865 | 29.06% Increase | 38.54% Increase |
| Net Profit / (Loss) | 34,513 | (8,764) | 20,608 | 493.80% Increase | 67.47% Increase |
Niva Bupa Health Insurance Company Limited, formerly known as Max Bupa, is a prominent standalone health insurance provider in India. The company operates as a joint venture, leveraging international healthcare expertise to provide a wide range of insurance products, including individual, family, and senior citizen plans. In 2025, Niva Bupa continued its expansion by strengthening its digital distribution channels and forming strategic bank partnerships to enhance market penetration. The company maintains a healthy solvency ratio of 2.48 as of March 31, 2026, ensuring strong financial stability to meet policyholder obligations. Prominent institutional investors, including True North and Bupa, remain key stakeholders, supporting the firm’s long-term growth and capital requirements.
Leave a Reply